Medication use, service utilization, and medical costs associated with new episodes of bipolar disorder: Evidence from a retrospective claims database

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 9, Issue 4, 2007, Pages 280-286

  Ohsfeldt, Robert L ^a   Lage, Maureen J ^b   Rajagopalan, Krithika ^c,d  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b HealthMetrics Outcomes Research LLC   (United States)

^c ASTRAZENECA   (United Kingdom)

^d BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; BUSPIRONE; CARBAMAZEPINE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CITALOPRAM; CLONAZEPAM; CLOZAPINE; DIAZEPAM; ETIRACETAM; GABAPENTIN; HALOPERIDOL; HYDRAZINE; LAMOTRIGINE; LITHIUM; LORAZEPAM; OLANZAPINE; OXAZEPAM; OXCARBAZEPINE; PERPHENAZINE; PRIMIDONE; QUETIAPINE; RISPERIDONE; TIAGABINE; TOPIRAMATE; UNINDEXED DRUG; VALPROATE SEMISODIUM; ZIPRASIDONE; ZONISAMIDE;

ADULT; ARTICLE; BIPOLAR DISORDER; CONSULTATION; DATA BASE; DEPRESSION; DRUG COST; DRUG USE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; PRACTICE GUIDELINE; RETROSPECTIVE STUDY;

EID: 34547686386     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/pcc.v09n0405     Document Type: Article

References (18)

1. Kessler RC, Chiu WT, Demier O, et al. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch Gen Psychiatry 2005;62:617-627
2. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 2003;73:123-131
3. Kleinman L, Lowin A, Flood E, et al. Costs of bipolar disorder. Pharmacoeconomics 2003;21:601-622
4. Woods SW. The economic burden of bipolar disease. J Clin Psychiatry 2000;61(suppl 13):38-41
5. American Psychiatric Association. Part A: treatment recommendations for patients with bipolar disorder. Am J Psychiatry 2002;159(suppl 4):4-15
6. Keck PE Jr, Perlis RH, Otto MW, et al. The expert consensus guideline series: treatment of bipolar disorder 2004. Postgrad Med Special Report. December 2004:1-120
7. Lim PZ, Tunis SL, Edell WS, et al. Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines. Bipolar Disord 2001;3:165-173
8. SAS User's Guide. SAS/STAT User's Guide: Version 8. Cary, NC: SAS Institute; 1999
9. Suppes T, Dennehy EB, Swann AC, et al. Report of the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder 2000. J Clin Psychiatry 2002;63:288-299
10. The World Federation of Societies of Biological Psychiatry (WFSBP). Guidelines for the biological treatment of bipolar disorders, pt 1: treatment of bipolar depression. World J Biol Psychiatry 2002;3:115-124
11. The World Federation of Societies of Biological Psychiatry (WFSBP). Guidelines for the biological treatment of bipolar disorders, pt 2: treatment of mania. World J Biol Psychiatry 2003;4:5-13
12. Ghaemi SN, Hsu DJ, Soldani F, et al. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord 2003;5:421-433
13. Algorithms and the medication treatment of people with serious mental illnesses [National Association of State Mental Health Program Directors Web site]. Dec 1997. Available at: http://www.nasmhpd.org/general_files/ publications/med_directors_pubs/meddir2.htm. Accessed Aug 2006
14. Bryant-Comstock L, Stender M, Devercelli G. Health care utilization and costs among privately insured patients with bipolar I disorder. Bipolar Disord 2002;4:398-405
15. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602
16. American Psychiatric Association. Practice guidelines for major depressive disorder in adults. Am J Psychiatry 1993;150:1-26
17. Birnbaum HG, Cremieux PY, Greenberg PE, et al. Management of major depression in the workplace. Dis Manage Health Outcomes 2002;7:163-171
18. Marciniak MD, Lage MJ, Dunayevich E, et al. The cost of treating anxiety: the medical and demographic correlates that impact total medical costs. Depress Anxiety 2005;21:178-184